Synthesis and Biological Evaluation of Novel Heterocyclic Imines Linked Coumarin-Thiazole Hybrids as Anticancer Agents.

BACKGROUND Human Galectin-1, protein of lectin family showing affinity towards β-galactosides has emerged as critical regulator of tumor progression and metastasis, by modulating diverse biological events including homotypic cell aggregation, migration, apoptosis, angiogenesis and immune escape. Therefore, galectin-1 inhibitors might represent novel therapeutic agents for cancer. METHODS A new series of heterocyclic imines linked coumarin-thiazole hybrids (6a-6r) has been synthesized and evaluated for their cytotoxic potential against a panel of six human cancer cell lines namely, lung (A549), prostate (DU-145), breast (MCF-7 & MDA-MB-231), colon (HCT-15 & HT-29) using MTT assay. Characteristic apoptotic assays like DAPI staining, cell cycle, annexin V and Mitochondrial membrane potential studies are performed for most active compound. Further Gal-1 inhibition was confirmed by ELISA and fluorescence spectroscopy. RESULTS Among all, the compound 6g {3-(2-(2-(pyridin-2-ylmethylene) hydrazineyl) thiazol-4-yl)-2H-chromen-2-one} exhibited promising growth inhibition against HCT-15 colorectal cancer cells with an IC50 value of 1.28 ± 0.14 µM. The characteristic apoptotic morphological features like chromatin condensation, membrane blebbing and apoptotic body formation were clearly observed with compound 6g on HCT-15 cells using DAPI staining studies. Further, annexin V-FITC/PI assay confirmed effective early apoptosis induction by treatment with compound 6g. Loss of mitochondrial membrane potential and enhancing ROS generation were confirmed with JC-1 and DCFDA staining method respectively by treatment with compound 6g, suggest a possible mechanism for inducing apoptosis. Moreover, flow cytometric analysis revealed that compound 6g blocks G0/G1 phase of the cell cycle in a dose dependent manner. The compound 6g effectively reduces the levels of Gal-1 protein in a dose dependent manner. The binding constant (Ka) of 6g with Gal-1 was calculated from the intercept value which was observed as 1.9 x 107 M-1 by Fluorescence spectroscopy. Molecular docking studies showed strong interactions of compound 6g with Gal-1 protein. CONCLUSION Our studies demonstrate the anticancer potential and Gal-1 inhibition of heterocyclic imines linked coumarin-thiazole hybrids.

[1]  Xianlin Xu,et al.  Prognostic significance of galectin-1 expression in patients with cancer: a meta-analysis , 2018, Cancer Cell International.

[2]  W. Fayad,et al.  Novel hydrazide-hydrazone and amide substituted coumarin derivatives: Synthesis, cytotoxicity screening, microarray, radiolabeling and in vivo pharmacokinetic studies. , 2018, European journal of medicinal chemistry.

[3]  Mahantesh M. Kurjogi,et al.  Synthesis of coumarin-theophylline hybrids as a new class of anti-tubercular and anti-microbial agents. , 2018, European journal of medicinal chemistry.

[4]  A. Leite,et al.  Synthesis, anticancer activity and mechanism of action of new thiazole derivatives. , 2018, European journal of medicinal chemistry.

[5]  R. Griffin,et al.  Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models , 2017, International journal of molecular sciences.

[6]  Pankaj Sharma,et al.  Synthesis of substituted phenanthrene-9-benzimidazole conjugates: Cytotoxicity evaluation and apoptosis inducing studies. , 2017, European journal of medicinal chemistry.

[7]  D. Vodnar,et al.  Synthesis of 2-phenylamino-thiazole derivatives as antimicrobial agents , 2017 .

[8]  K. Baheti,et al.  Synthesis and pharmacological evaluation of 5-methyl-2-phenylthiazole-4-substituted heteroazoles as a potential anti-inflammatory and analgesic agents , 2016 .

[9]  V. Kojić,et al.  Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position. , 2016, European journal of medicinal chemistry.

[10]  A. Mohamad,et al.  Coumarins as Potential Antioxidant Agents Complemented with Suggested Mechanisms and Approved by Molecular Modeling Studies , 2016, Molecules.

[11]  R. Singla,et al.  Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies. , 2015, European journal of medicinal chemistry.

[12]  A. Shafiee,et al.  Recent applications of 1,3-thiazole core structure in the identification of new lead compounds and drug discovery. , 2015, European journal of medicinal chemistry.

[13]  C. Pungitore,et al.  Coumarins as Potential Inhibitors of DNA Polymerases and Reverse Transcriptases. Searching New Antiretroviral and Antitumoral Drugs. , 2015, Current drug discovery technologies.

[14]  Vineeta Singh,et al.  Design, synthesis and biological evaluation of some new coumarin derivatives as potential antimicrobial agents. , 2015, Medicinal chemistry (Shariqah (United Arab Emirates)).

[15]  K. Sashidhara,et al.  Design and synthesis of new series of coumarin-aminopyran derivatives possessing potential anti-depressant-like activity. , 2015, Bioorganic & medicinal chemistry letters.

[16]  U. Nilsson,et al.  Synthesis and evaluation of iminocoumaryl and coumaryl derivatized glycosides as galectin antagonists. , 2014, Bioorganic & medicinal chemistry letters.

[17]  S. Bondock,et al.  Anticancer activity of new coumarin substituted hydrazide-hydrazone derivatives. , 2014, European journal of medicinal chemistry.

[18]  E. Raymond,et al.  Unraveling galectin-1 as a novel therapeutic target for cancer. , 2014, Cancer treatment reviews.

[19]  J. Cresswell,et al.  Effects of the neonicotinoid pesticide thiamethoxam at field-realistic levels on microcolonies of Bombus terrestris worker bumble bees. , 2014, Ecotoxicology and environmental safety.

[20]  U. Patil,et al.  Evaluation of antihyperlipidemic and antitumor activities of isolated coumarins from Salvadora indica , 2014, Pharmaceutical biology.

[21]  P. Gopalakrishnakone,et al.  Apoptogenic activity of ethyl acetate extract of leaves of Memecylon edule on human gastric carcinoma cells via mitochondrial dependent pathway. , 2013, Asian Pacific journal of tropical medicine.

[22]  Li-wu Fu,et al.  Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety. , 2012, European journal of medicinal chemistry.

[23]  Amy H. Andreotti,et al.  In Vivo Consequences of Disrupting SH3-Mediated Interactions of the Inducible T-Cell Kinase , 2012, Journal of signal transduction.

[24]  Jun-qing Chen,et al.  Design, synthesis, and in vitro antiproliferative activity of novel Dasatinib derivatives. , 2012, Bioorganic & medicinal chemistry letters.

[25]  P. Pinton,et al.  Mitochondria-Ros Crosstalk in the Control of Cell Death and Aging , 2011, Journal of signal transduction.

[26]  S. Katiyar,et al.  Grape Proanthocyanidins Induce Apoptosis by Loss of Mitochondrial Membrane Potential of Human Non-Small Cell Lung Cancer Cells In Vitro and In Vivo , 2011, PloS one.

[27]  A. Mallika,et al.  Antiproliferative activity and standardization of Tecomella undulata bark extract on K562 cells. , 2011, Journal of ethnopharmacology.

[28]  L. Goldani,et al.  Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole. , 2010, Current opinion in investigational drugs.

[29]  Sachiko Sato,et al.  Synthesis of stable and selective inhibitors of human galectins-1 and -3. , 2008, Bioorganic & medicinal chemistry.

[30]  F. Bamoharram,et al.  The synthesis of coumarin-3-carboxylic acids and 3-acetyl-coumarin derivatives using heteropolyacids as heterogeneous and recyclable catalysts , 2008 .

[31]  M. F. Troncoso,et al.  Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival , 2007, Cellular and Molecular Life Sciences.

[32]  I. Doytchinova,et al.  Synthesis and antiproliferative activity of benzo[d]isothiazole hydrazones. , 2006, European journal of medicinal chemistry.

[33]  Jong-Suk Kim,et al.  Scopoletin induces apoptosis in human promyeloleukemic cells, accompanied by activations of nuclear factor kappaB and caspase-3. , 2005, Life sciences.

[34]  L. Saravolatz,et al.  Nitazoxanide: a new thiazolide antiparasitic agent. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  G. Rabinovich.  Galectin-1 as a potential cancer target , 2005, British Journal of Cancer.

[36]  S. Bhagwat,et al.  Lead identification of a potent benzopyranone selective estrogen receptor modulator. , 2004, Bioorganic & medicinal chemistry letters.

[37]  R. Zeldin,et al.  Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients. , 2003, The Journal of antimicrobial chemotherapy.

[38]  B. Creaven,et al.  Modulation of mitogen-activated protein kinases by 6-nitro-7-hydroxycoumarin mediates apoptosis in renal carcinoma cells. , 2003, European journal of pharmacology.

[39]  A. Gürsoy,et al.  Synthesis and anticancer evaluation of some new hydrazone derivatives of 2,6-dimethylimidazo[2,1-b][1,3,4]thiadiazole-5-carbohydrazide. , 2003, European journal of medicinal chemistry.

[40]  M. Sprung.  A Summary of the Reactions of Aldehydes with Amines. , 1940 .

[41]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[42]  Antje Sommer,et al.  Principles Of Fluorescence Spectroscopy , 2016 .

[43]  O. Firuzi,et al.  4-Methylcoumarin derivatives with anti-inflammatory effects in activated microglial cells. , 2014, Biological & pharmaceutical bulletin.

[44]  Yuriko Tanaka,et al.  The effects of nizatidine on transient lower esophageal sphincter relaxations (TLESRs) and acid reflux in healthy subjects. , 2011, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi.

[45]  J H Nicholson,et al.  DAPI as a useful stain for nuclear quantitation. , 1991, Biotechnic & histochemistry : official publication of the Biological Stain Commission.